Breast Neoplasms: all 12,820 studies
Page 107 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic ImagingWithdrawnNCT01277263
- An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)TerminatedNCT01277133
- Exclusive Intraoperative Radiation Therapy for Breast CancerCompletedNCT01276938Phase 2/3
- Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer PatientsCompletedNCT01276899
- Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast CancerStatus unknownNCT01276769Phase 2
- Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT01276496Phase 1
- Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast CancerCompletedNCT01275859Phase 2
- Take-Care Program: Effectiveness of a Physical Therapy Program on Cancer Related SymptomsCompletedNCT01274806Not applicable
- Usefulness of Ki67 Index in Hormone Receptor-positive Breast CancerCompletedNCT01273415
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedNCT01273168Phase 1
- Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer SurvivorsCompletedNCT01272570
- Quality of Life in Breast Cancer Patients and SurvivorsCompletedNCT01272401
- Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With TrastuzumabCompletedNCT01271920Phase 1/2
- Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerCompletedNCT01271738Not applicable
- NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After?Status unknownNCT01270373Phase 2
- Study of Axillary Lymphadenectomy Without Drainage for Breast CancerCompletedNCT01267552Phase 2/3
- Effect of Metformin on Breast Cancer MetabolismCompletedNCT01266486Phase 2
- Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenStatus unknownNCT01266213Phase 2
- A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast CancerCompletedNCT01265927Phase 1
- Reasons for Changing HOrmonal Therapy of Advanced Breast CancerCompletedNCT01265654
- Prognostic Value of Stem Cell Related MarkersWithdrawnNCT01265225
- Cognition in Breast Cancer Patients: The Impact of Cancer-related StressCompletedNCT01264562
- Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast CancerCompletedNCT01263613Early Phase 1
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast CancerCompletedNCT01263145Phase 1
- A Novel Therapy for the Treatment of Chest Wall Progression of Breast CancerCompletedNCT01262716
- Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.CompletedNCT01262469Phase 2
- Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerTerminatedNCT01262274Phase 2
- Safety Study of Multiple-Vaccine to Treat Metastatic Breast CancerCompletedNCT01259505Phase 1
- Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic ImagingWithdrawnNCT01257932
- Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving TherapyCompletedNCT01257152
- Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionCompletedNCT01256801
- Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT01256762Phase 2
- Delayed-Delayed Breast ReconstructionCompletedNCT01256528Not applicable
- Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerStatus unknownNCT01254591Not applicable
- Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT01254526Phase 1
- Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerTerminatedNCT01254136Phase 1/2
- BRCA Mutations in LatinasCompletedNCT01251900
- Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerActive, not recruitingNCT01251874Phase 1
- Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer PatientsCompletedNCT01249456
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast CancerCompletedNCT01248494Phase 1
- Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast CancerStatus unknownNCT01247480
- Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot StudyStatus unknownNCT01247467
- Breast Cancer Registry - National University Health System, SingaporeStatus unknownNCT01247441
- Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast CancerActive, not recruitingNCT01247233Not applicable
- Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood FlowCompletedNCT01247129Phase 2
- MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot StudyStatus unknownNCT01246856
- Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast CancerCompletedNCT01246427Phase 3
- AT13387 in Adults With Refractory Solid TumorsCompletedNCT01246102Phase 1
- Radiation Therapy in Treating Patients With Stage 0-II Breast CancerActive, not recruitingNCT01245712Phase 2
- Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast CancerCompletedNCT01245205Phase 1
- Pilot Clinical Trial (Phase II) of Inquiry-based Stress Reduction (IBSR) Program for Survivors of Breast CancerCompletedNCT01244087
- Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelTerminatedNCT01243541Not applicable
- Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast CancerCompletedNCT01242449Phase 2
- Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast CancerCompletedNCT01241721Not applicable
- Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast CancerWithdrawnNCT01240941Phase 2
- MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast CancerWithdrawnNCT01240928Phase 1
- Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant ChemotherapyCompletedNCT01240681Not applicable
- An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer RefractoryApproved for marketingNCT01240421
- Vitamin D, Diet and Activity StudyCompletedNCT01240213Not applicable
- GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine TherapyTerminatedNCT01239251
- Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast CancerCompletedNCT01238952Phase 1
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTerminatedNCT01238133Phase 1
- Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerTerminatedNCT01238029Phase 1
- Exercise Intervention in Breast Cancer Patients With Treatment-Induced ArthralgiaCompletedNCT01236417Not applicable
- A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)CompletedNCT01234857Phase 2
- Study of AFP464 +/- Faslodex in ER + Breast CancerTerminatedNCT01233947Phase 2
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTerminatedNCT01233505Phase 1
- Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast CancerTerminatedNCT01232881
- Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01232062
- Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast CancerStatus unknownNCT01231802Phase 2
- MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast CancerCompletedNCT01231386
- Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)CompletedNCT01231022
- Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast CancerTerminatedNCT01230970Phase 2
- The Physical and Psychological Benefits of Yoga and Breast CancerCompletedNCT01230671Phase 1
- Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast CancerWithdrawnNCT01229605Phase 2
- Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput PlatformsStatus unknownNCT01227733
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
- Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesCompletedNCT01226316Phase 1
- Participation Restrictions in Breast Cancer SurvivorsCompletedNCT01225328Not applicable
- Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PETStatus unknownNCT01224873
- A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and TamoxifenCompletedNCT01223833
- Endoscopic Breast Surgery in Treating Patients With Breast CancerTerminatedNCT01222377Not applicable
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsStatus unknownNCT01222052Phase 3
- Tesetaxel as First-line Therapy for Metastatic Breast CancerStatus unknownNCT01221870Phase 2
- Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast CancerCompletedNCT01221688Not applicable
- Effect of Early vs Late Drainage Removal in Women After Radical Mastectomy With Axillary ClearanceStatus unknownNCT01221064Not applicable
- Art Therapy Intervention for Breast Cancer PatientsCompletedNCT01220960Not applicable
- The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)CompletedNCT01220570Phase 1
- Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+CompletedNCT01220076Phase 2
- Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerWithdrawnNCT01219907Phase 1
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA GeneCompletedNCT01219699Phase 1
- Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast CancerCompletedNCT01219075Not applicable
- Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast TumorsCompletedNCT01218529Phase 2
- Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast SurgeryStatus unknownNCT01217593Not applicable
- Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency ElectrocoagulationStatus unknownNCT01216254Phase 4
- Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)CompletedNCT01216111Phase 3
- Exploratory Study of Breast Cancer With ABY025CompletedNCT01216033Phase 1/2
- Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast CancerCompletedNCT01215162Phase 2
- Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerTerminatedNCT01212887Phase 1